<DOC>
	<DOC>NCT02308124</DOC>
	<brief_summary>Compare the effect of treatment of midodrine and pyridostigmine in neurogenic orthostatic hypotension and investigate the quality of life of treatment of neurogenic orthostatic hypotension.</brief_summary>
	<brief_title>Treatment and Prognosis of Neurogenic Orthostatic Hypotension : A Prospective Randomized Study</brief_title>
	<detailed_description />
	<mesh_term>Hypotension</mesh_term>
	<mesh_term>Hypotension, Orthostatic</mesh_term>
	<mesh_term>Bromides</mesh_term>
	<mesh_term>Pyridostigmine Bromide</mesh_term>
	<mesh_term>Midodrine</mesh_term>
	<criteria>age &gt;=18 patients who complained of dizziness Orthostatic hypotension after 3minute standing (systolic blood pressure drop &gt;=20 or diastolic blood pressure drop &gt;=10 Druginduced hypotension, if necessary, evaluate patient after discontinuing the causative drug for one month Heart failure or Chronic renal failure Patients who cannot or do not want to write questionaires. Poor drug compliance</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>